Merus NV (2GH)

Frankfurt
Currency in EUR
44.80
-0.40(-0.88%)
Delayed Data·
2GH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
2GH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
44.8044.80
52 wk Range
29.4056.50
Key Statistics
Edit
Bid/Ask
44.60 / 47.00
Prev. Close
45.2
Open
44.8
Day's Range
44.8-44.8
52 wk Range
29.4-56.5
Volume
-
Average Volume (3m)
109
1-Year Change
-12.23%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2GH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Merus NV News & Analysis

Show more

Merus NV Company Profile

Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes BIZENGRI for the treatment of patients with pancreatic adenocarcinoma or non-small cell lung cancer (NSCLC) and non Neuregulin 1. The company is also developing MCLA-158 for the treatment of solid tumors; MCLA-129 for the treatment of patients with lungs and other solid tumors; ONO-4685 to treat relapsed/refractory T cell lymphoma; and INCA33890 for advanced solid tumors. In addition, it has collaboration agreement with Eli Lilly and Company, Ono Pharmaceutical Co., Ltd., and Betta Pharmaceuticals Co. Ltd. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

Compare 2GH to Peers and Sector

Metrics to compare
2GH
Peers
Sector
Relationship
P/E Ratio
−14.1x−1.3x−0.5x
PEG Ratio
0.280.080.00
Price/Book
6.6x2.6x2.6x
Price / LTM Sales
71.6x7.1x3.0x
Upside (Analyst Target)
-130.6%51.5%
Fair Value Upside
Unlock19.7%9.4%Unlock

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-1.40 / --
Revenue / Forecast
26.49M / --
EPS Revisions
Last 90 days

2GH Income Statement

People Also Watch

7.000
NVTS
+2.04%
170.00
CRWV
-1.12%
37.97
NNE
+13.38%
537.92
ARGX
-0.52%
62.02
OKLO
-1.19%

FAQ

What Is the Merus NV (2GH) Stock Price Today?

The Merus NV stock price today is 44.80

What Stock Exchange Does Merus NV Trade On?

Merus NV is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Merus NV?

The stock symbol for Merus NV is "2GH."

What Is the Merus NV Market Cap?

As of today, Merus NV market cap is 3.41B.

What Is Merus NV's Earnings Per Share (TTM)?

The Merus NV EPS (TTM) is -4.14.

From a Technical Analysis Perspective, Is 2GH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Merus NV Stock Split?

Merus NV has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.